134 related articles for article (PubMed ID: 22786763)
1. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.
Nielsen TT; Mizielinska S; Hasholt L; Isaacs AM; Nielsen JE;
J Gene Med; 2012 Aug; 14(8):521-9. PubMed ID: 22786763
[TBL] [Abstract][Full Text] [Related]
2. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
[TBL] [Abstract][Full Text] [Related]
3. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
Cheruiyot A; Lee JA; Gao FB; Ahmad ST
FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
[TBL] [Abstract][Full Text] [Related]
6. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
Clayton EL; Milioto C; Muralidharan B; Norona FE; Edgar JR; Soriano A; Jafar-Nejad P; Rigo F; Collinge J; Isaacs AM
Brain; 2018 Dec; 141(12):3428-3442. PubMed ID: 30496365
[TBL] [Abstract][Full Text] [Related]
7. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia.
Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S
J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
[TBL] [Abstract][Full Text] [Related]
9. The role of CHMP2B
Krasniak CS; Ahmad ST
Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
[TBL] [Abstract][Full Text] [Related]
10. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B.
Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK
Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal dementia caused by CHMP2B mutations.
Isaacs AM; Johannsen P; Holm I; Nielsen JE;
Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
[TBL] [Abstract][Full Text] [Related]
12. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
[TBL] [Abstract][Full Text] [Related]
13. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
[TBL] [Abstract][Full Text] [Related]
14. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
[TBL] [Abstract][Full Text] [Related]
15. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias.
Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB
Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997
[TBL] [Abstract][Full Text] [Related]
16. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
[TBL] [Abstract][Full Text] [Related]
17. Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia, is required for autophagosome maturation.
Lu Y; Zhang Z; Sun D; Sweeney ST; Gao FB
Mol Cell; 2013 Oct; 52(2):264-71. PubMed ID: 24095276
[TBL] [Abstract][Full Text] [Related]
18. Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity.
Wilson C; Kavaler J; Ahmad ST
Dev Neurobiol; 2020 Mar; 80(3-4):85-97. PubMed ID: 31587468
[TBL] [Abstract][Full Text] [Related]
19. Molecular Genetics of Frontotemporal Dementia Elucidated by
Vandal SE; Zheng X; Ahmad ST
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
